DoD awards Ellume $231M to increase US production of at-home, OTC COVID-19 test

The Department of Defense, in coordination with HHS, awarded $231.8 million to Australia's Ellume to expand U.S. production of a rapid at-home test for COVID-19.
The contract, awarded Monday, includes the purchase of 8.5 million antigen tests for nationwide distribution as part of President Joe Biden's pandemic response effort.